Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Curr Opin HIV AIDS. 2011 Mar;6(2):131–140. doi: 10.1097/COH.0b013e328343ad03

Figure 1.

Figure 1

Categorization tree for recently published (2009 onwards) HIV transmission models incorporating ARV resistance. All included models involve transmission of resistant and wild-type HIV strains, with all models but Bhunu et al following the structure of Figure 2a (6).) “Treatment” refers to all forms of ARV therapy or prophylaxis: cART, PrEP or ARV-VMB. “Transmitted resistance tracked” refers to tracking TDR and acquired resistance separately. Model assumptions and/or details: * there is a cost of resistance, in terms of reduced infectiousness of resistant strains; ** investigation of the potential effect of risk compensation. Abbas et al is not included in this figure as full details of their model are not available from the conference abstract (12).